What testosterone formulation and dosing should be prescribed for a patient with a serum testosterone of 456 ng/dL who seeks injections to treat decreased libido, fatigue, and erectile dysfunction?

Do Not Initiate Testosterone Therapy for This Patient

A testosterone level of 456 ng/dL does not meet diagnostic criteria for hypogonadism, and testosterone therapy should not be prescribed. This patient requires proper diagnostic workup and consideration of alternative causes for his symptoms before any hormonal intervention.

Why Testosterone Therapy Is Not Indicated

Testosterone Level Is Not Low

• The patient's testosterone of 456 ng/dL is well above the diagnostic threshold for hypogonadism
• Endocrine Society guidelines define hypogonadism as testosterone <264-300 ng/dL on at least 2 fasting morning samples 1, 2, 1
• This level falls within the normal physiologic range for adult men 3
• The American College of Physicians explicitly states that testosterone does not improve sexual function in men without testosterone levels in the hypogonadal range 4

Proper Diagnostic Requirements Not Met

Before even considering testosterone therapy, the following must be documented:

Required Laboratory Criteria:

• Two separate fasting morning (7-10 AM) testosterone measurements showing levels <264-300 ng/dL 1, 2, 1
• Confirmation with calculated free testosterone if obesity, diabetes, or conditions affecting SHBG are present 3
• Measurement of LH and FSH to distinguish primary from secondary hypogonadism 1

Clinical Assessment Needed:

• Evaluation for underlying reversible causes of symptoms (obesity, medications, severe illness) 3
• Assessment for other medical conditions causing fatigue and erectile dysfunction
• Consideration of psychological factors, relationship issues, and depression 5

What Should Be Done Instead

Address Erectile Dysfunction Appropriately

• First-line therapy for ED is PDE-5 inhibitors (sildenafil, tadalafil, vardenafil), not testosterone 5
• PDE-5 inhibitors show strong evidence for efficacy in men with ED regardless of testosterone status 5
• Evaluate for cardiovascular risk factors, diabetes, hypertension, and vascular disease
• Assess medications that may contribute to ED

Investigate Fatigue and Libido Concerns

• Screen for depression using validated instruments like BDI 6
• Evaluate sleep quality and screen for sleep apnea 2, 7
• Assess for metabolic syndrome, diabetes, and thyroid dysfunction
• Review all current medications, particularly opioids, corticosteroids, and antihypertensives 3
• Consider obesity as a primary contributor if BMI ≥30 3

If Obesity Is Present

Weight loss is the first-line treatment for obesity-related sexual dysfunction and fatigue 3:

• Weight loss of ≥5% significantly improves testosterone levels naturally
• Associated with improved physical function, libido, and erectile function
• More appropriate than hormonal intervention when testosterone is not truly deficient

Critical Pitfalls to Avoid

Prescribing Testosterone Without Proper Indication

• Testosterone therapy in men with normal testosterone levels does not improve sexual function 4
• Creates unnecessary risks: erythrocytosis (hematocrit >54%), cardiovascular events, prostate concerns 2
• Requires lifelong monitoring of hematocrit, PSA, and testosterone levels 2
• May suppress endogenous testosterone production and fertility

Misattributing Symptoms to Testosterone

The symptoms described (decreased libido, fatigue, ED) are nonspecific and commonly caused by:

• Depression and mood disorders
• Cardiovascular disease
• Diabetes and metabolic syndrome
• Medication side effects
• Sleep disorders
• Relationship issues

Ignoring Evidence-Based Guidelines

• The Endocrine Society explicitly recommends against offering testosterone to all men with low-normal testosterone 1
• The American College of Physicians found insufficient evidence for testosterone in men without confirmed hypogonadism 5
• FDA labeling requires testosterone products be used only for confirmed hypogonadism due to known causes 8

If Hypogonadism Were Confirmed (Which It Is Not)

Only for educational context, if this patient had documented testosterone <264-300 ng/dL on two occasions, the approach would be:

Injectable Testosterone Options:

• Testosterone cypionate or enanthate: 75-100 mg IM weekly, or 150-200 mg every 2 weeks 1, 9
• Smaller, more frequent doses (weekly) provide more stable levels than larger doses every 2-3 weeks 7, 10
• Measure testosterone midway between injections; adjust if >700 ng/dL or <400 ng/dL 2, 1

Mandatory Monitoring:

• Baseline: hematocrit, PSA, digital rectal exam 2, 7
• At 3-6 months: testosterone level, hematocrit, symptom assessment 2
• Annually: hematocrit, PSA (if age >40), symptom reassessment 2
• Stop therapy if hematocrit >54% 2

But again, this patient does not meet criteria for treatment.